BVF INC/IL - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$55,282,000
-33.7%
1,193,224
-65.1%
6.04%
-35.3%
Q1 2019$83,393,000
+23.4%
3,420,562
-27.9%
9.34%
+5.7%
Q4 2018$67,603,000
-29.3%
4,744,062
-24.6%
8.84%
+5.2%
Q3 2018$95,617,000
+22.0%
6,290,586
+34.6%
8.40%
+9.8%
Q2 2018$78,399,000
-5.1%
4,672,195
-7.7%
7.65%
-8.6%
Q1 2018$82,624,000
-25.7%
5,062,768
-41.7%
8.38%
-37.5%
Q4 2017$111,187,000
+41.2%
8,686,498
+35.7%
13.40%
+33.9%
Q3 2017$78,751,000
+55.3%
6,402,525
+5.7%
10.01%
+27.1%
Q2 2017$50,719,000
+105.3%
6,059,625
+119.3%
7.88%
+87.5%
Q1 2017$24,702,000
-43.6%
2,763,086
-44.6%
4.20%
-52.3%
Q4 2016$43,829,000
+0.5%
4,986,186
-22.8%
8.81%
+7.2%
Q3 2016$43,613,000
+48.3%
6,461,186
-21.8%
8.22%
+31.2%
Q2 2016$29,409,000
+27.0%
8,260,897
+5.2%
6.26%
+9.3%
Q1 2016$23,158,000
-17.9%
7,850,211
+17.5%
5.73%
+19.2%
Q4 2015$28,201,000
-36.1%
6,682,711
-31.0%
4.81%
-46.1%
Q3 2015$44,144,000
-33.2%
9,680,630
+5.6%
8.92%
-23.6%
Q2 2015$66,110,000
-4.6%
9,169,276
-2.5%
11.67%
-19.5%
Q1 2015$69,321,000
+24.5%
9,405,817
-20.1%
14.50%
+33.8%
Q4 2014$55,683,000
+12.4%
11,772,335
-15.2%
10.83%
+5.3%
Q3 2014$49,539,000
-26.2%
13,876,513
-5.7%
10.29%
-3.1%
Q2 2014$67,104,000
+68.2%
14,715,786
+73.4%
10.61%
+71.6%
Q1 2014$39,889,000
+5.4%
8,486,927
+12.4%
6.18%
-6.6%
Q4 2013$37,841,000
-37.4%
7,553,089
-22.3%
6.62%
-36.4%
Q3 2013$60,456,000
+19.6%
9,719,589
-12.7%
10.40%
+6.1%
Q2 2013$50,539,00011,131,8589.81%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders